• 3801 Citations
  • 16 h-Index
1983 …2019

Research output per year

If you made any changes in Pure these will be visible here soon.

Fingerprint Dive into the research topics where E. Remenár is active. These topic labels come from the works of this person. Together they form a unique fingerprint.

  • 14 Similar Profiles

Network Recent external collaboration on country level. Dive into details by clicking on the dots.

Research Output

  • 3801 Citations
  • 16 h-Index
  • 59 Article
  • 4 Review article

Durvalumab for recurrent or metastatic head and neck squamous cell carcinoma: Results from a single-arm, phase II study in patients with ≥25% tumour cell PD-L1 expression who have progressed on platinum-based chemotherapy

Zandberg, D. P., Algazi, A. P., Jimeno, A., Good, J. S., Fayette, J., Bouganim, N., Ready, N. E., Clement, P. M., Even, C., Jang, R. W., Wong, S., Keilholz, U., Gilbert, J., Fenton, M., Braña, I., Henry, S., Remenar, E., Papai, Z., Siu, L. L., Jarkowski, A. & 5 others, Armstrong, J. M., Asubonteng, K., Fan, J., Melillo, G. & Mesía, R., Jan 2019, In : European Journal of Cancer. 107, p. 142-152 11 p.

Research output: Contribution to journalArticle

  • 29 Citations (Scopus)

    Local immune parameters as potential predictive markers in head and neck squamous cell carcinoma patients receiving induction chemotherapy and cetuximab

    Ladányi, A., Kapuvári, B., Papp, E., Tóth, E., Lövey, J., Horváth, K., Gődény, M. & Remenár, É., May 2019, In : Head and Neck. 41, 5, p. 1237-1245 9 p.

    Research output: Contribution to journalArticle

  • 2 Citations (Scopus)

    Patritumab or placebo, with cetuximab plus platinum therapy in recurrent or metastatic squamous cell carcinoma of the head and neck: A randomised phase II study

    Forster, M. D., Dillon, M. T., Kocsis, J., Remenár, É., Pajkos, G., Rolland, F., Greenberg, J. & Harrington, K. J., Dec 2019, In : European Journal of Cancer. 123, p. 36-47 12 p.

    Research output: Contribution to journalArticle

    Open Access